Trial · NCT01215253
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Patients With Ventricular Tachycardia (VT) or Ventricular Fibrillation (VF) or Death | 2 years of follow-up on average | Primary endpoint of the study will be defined as a composite endpoint consisting of Ventricular Tachycardia or Ventricular Fibrillation requiring antitachycardia pacing (ATP) therapy, implantable cardioverter-defibrillator (ICD) shock, or death, whichever occurs first. |
| Secondary | Number of Patients With VT or VF Requiring ICD Shock or Death | 2 years of follow-up on average | Implantable cardioverter-defibrillator (ICD) shock for VT or VF or death, whichever occurs first. |
| Secondary | Number of Recurrent Episodes of VT or VF Requiring Antitachycardia Pacing (ATP) or ICD Shock Therapies | 2 years of follow-up on average | Total number of recurrent ICD therapies requiring antitachycardia pacing (ATP) or shock will be analyzed, not just first event |
| Secondary | Number of Patients With First Inappropriate ICD Shock | 2 years of follow-up on average | Number of patients with first inappropriate ICD shock for other reasons than VT or VF |
| Secondary | Number of Patients With Hospitalization for Cardiac Causes or Death, Whichever Occurred First. | 2 years of follow-up on average | Number of patients with a composite endpoint of cardiovascular hospitalization or death, whichever occurred first. |
| Secondary | Number of Patients With Heart Failure Hospitalization or Death, Whichever Occurred First | 2 years of follow-up on average | Number of patients with a composite endpoint of heart failure hospitalization or death, whichever occurred first. |
| Secondary | Death | 2 years of follow-up on average | Death as a safety endpoint of the trial |
| Secondary | Mean Meters Walked in 6 Minutes | 1 year of follow-up | Exercise capacity measured by the 6-minute walk test |
| Secondary | Quality of Life Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) | 1 year follow-up | The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life. The scale ranges from 0-100 with lower scores indicating worse outcomes. |
| Secondary | Number of Recurrent Inappropriate ICD Shocks | 2 years of follow-up on average | Number of recurrent inappropriate ICD shocks in all patients combined. |
| Other | Number of Patients Whose First VT/VF Required Antitachycardia Pacing (ATP) | 2 years of follow-up on average | Number of patients whose first VT or VF required antitachycardia pacing (ATP) |
| Other | Number of Patients Whose First VT/VF Required ICD Shock | 2 years of follow-up on average | number of patients whose first VT or VF required ICD shock |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01215253/registered